Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 10, 2020 | Chief Medical Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 40,828 | -- | 197,301 | |
| Jan 10, 2020 | Chief Medical Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 20,108 | $9.46 | 177,193 | |
| Jan 10, 2020 | Director, Chief Operating Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 59,881 | -- | 405,076 | |
| Jan 10, 2020 | Director, Chief Operating Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 29,492 | $9.46 | 375,584 | |
| Jan 10, 2020 | Director, Chairman & CEO | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 163,313 | -- | 1,102,603 | |
| Jan 10, 2020 | Director, Chairman & CEO | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 64,264 | $9.46 | 1,038,339 | |
| Jan 10, 2020 | Chief Science Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 40,828 | -- | 540,059 | |
| Jan 10, 2020 | Chief Science Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 18,904 | $9.46 | 521,155 | |
| Jan 10, 2020 | Chief Financial Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 24,496 | -- | 202,487 | |
| Jan 10, 2020 | Chief Financial Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 12,065 | $9.46 | 190,422 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.